Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fate Therapeutics
AstraZeneca
Sun Yat-sen University
Oncology Institute of Southern Switzerland
National Cancer Institute (NCI)
Sanofi